1977
DOI: 10.1016/s0031-6989(77)80049-0
|View full text |Cite
|
Sign up to set email alerts
|

A clinical pharmacologist's view of drug hepatotoxicity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1978
1978
1983
1983

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 66 publications
0
1
0
Order By: Relevance
“…One reason for this has been the limited knowledge about the activity of drug-metabolizing enzymes in human livers. This is rather surprising since the needle biopsy is a routine method to confirm diagnosis in patients with liver diseases (25,26) and with druginduced hepatic injury (27) and the use of micromethods (23,28) makes it possible to determine the activity of drugmetabolizing enzymes and the hepatic histology in the same specimen. Moreover, plasma drug clearance is a quantitative measure ofliver function (29,30) and a useful tool for drug selection for patients with liver damage (31,32).…”
Section: Discussionmentioning
confidence: 99%
“…One reason for this has been the limited knowledge about the activity of drug-metabolizing enzymes in human livers. This is rather surprising since the needle biopsy is a routine method to confirm diagnosis in patients with liver diseases (25,26) and with druginduced hepatic injury (27) and the use of micromethods (23,28) makes it possible to determine the activity of drugmetabolizing enzymes and the hepatic histology in the same specimen. Moreover, plasma drug clearance is a quantitative measure ofliver function (29,30) and a useful tool for drug selection for patients with liver damage (31,32).…”
Section: Discussionmentioning
confidence: 99%